In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine.
Specifically, Dr. Gibbin-Lameira will show that:
- Dose-dependent experiments can be performed in 96-well plate format over long periods of time (> 2 days), reducing the need for time and labor-intensive multiple fixed-point measurements and eliminating cytotoxic/cytostatic effects arising from the use of labels, dyes, or phototoxic damage
- Metrics output from Nanolive’s proprietary software, EVE Analytics, can be used to generate statistically robust time-dependent EC50 values based on total dry mass; a metric unique to label-free imaging
- Sub-cellular spatial resolution combined with high content image analysis can be used to investigate a drugs’ mechanism of action
Please register below to watch the webinar on-demand.
Read our latest news
Cytotoxic Drug Development Application Note
Discover how Nanolive’s LIVE Cytotoxicity Assay transforms cytotoxic drug development through high-resolution, label-free quantification of cell health and death. Our application note explores how this advanced technology enables real-time monitoring of cell death...
Investigative Toxicology Application Note
Our groundbreaking approach offers a label-free, high-content imaging solution that transforms the way cellular health, death, and phenotypic responses are monitored and quantified. Unlike traditional cytotoxicity assays, Nanolive’s technology bypasses the limitations...
Phenotypic Cell Health and Stress Application Note
Discover the advanced capabilities of Nanolive’s LIVE Cytotoxicity Assay in an application note. This document presents a detailed exploration of how our innovative, label-free technology enables researchers to monitor phenotypic changes and detect cell stress...